BLIS Technologies Limited has finalised a distribution agreement with Orange Daylily, to act as the distributor in China for Blis' branded finished goods product line, BLIS Probiotics in China. Orange Daylily will provide digital marketing, ecommerce operations and logistics support in China and will implement the launch of BLIS Probiotics on Alibaba's Tmall and Taobao, and Alipay platforms. Orange Daylily will also distribute BLIS Probiotics through JD Health - the health care and retailer pharmacy platform of JD.com, China's largest online retailer.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0150 NZD | 0.00% |
|
-6.25% | 0.00% |
Feb. 03 | NZX Midday Sector Update: Health Tech Soars, Electronic Tech Struggles | MT |
Jan. 09 | NZX Biggest Losers | MT |
Stocks mentioned in the article
Price |
Change |
5d. change |
Capi. | ||
---|---|---|---|---|---|
121.96USD | +2.02% | +18.67% | 270B | ||
41.31USD | +4.34% | +2.99% | 57.39B | ||
0.0150NZD | 0.00% | -6.25% | 10.86M | ||
Annual profits - Rate of surprise
- Stock Market
- Equities
- BLT Stock
- News BLIS Technologies Limited
- BLIS Technologies Limited Finalizess Distribution Agreement with Orange Daylily